SpecCheck vs Ekho
Side-by-side comparison of AI visibility scores, market position, and capabilities
SF optical industry B2B platform unifying eyewear ordering, tracking, and billing for eye care professionals; YC W23 $3.82M Initialized Capital seed targeting $68.3B US optical market fragmented across doctors, labs, and insurers.
About
SpecCheck is a San Francisco-based optical industry B2B platform — backed by Y Combinator (W23) with $3.82 million raised including a $3.7 million seed round led by Initialized Capital in October 2023 — providing eye care professionals and optical businesses with a unified prescription eyewear ordering, tracking, and billing system that connects optometrists, opticians, and optical labs in a single workflow to eliminate the manual coordination, phone calls, and paper-based processes that dominate the $68.3 billion US optical industry. Founded in 2023, SpecCheck addresses the fragmentation in optical dispensing workflow where prescriptions travel between eye doctors, dispensing opticians, and fulfillment labs through a mix of fax, phone, and disconnected software systems.
End-to-end vehicle commerce platform automating titling, registration, and compliance for OEM national sales; $17.3M from Activant, JPMorgan Payments, and Winnebago with 20+ OEM customers.
About
Ekho is an end-to-end vehicle commerce platform that provides digital sales infrastructure for automotive dealers and OEMs — handling the complete transaction lifecycle for nationwide vehicle sales including digital checkout, financing integration, titling, registration, and compliance management for vehicles sold across state lines. Founded and backed by Y Combinator, Activant Capital, JPMorgan Payments, and Winnebago Industries, Ekho raised $17.3 million total including a $15 million Series A, serving 20+ OEM customers including four publicly traded manufacturers.
AI Visibility Head-to-Head
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.